IRCT20110811007297N7
Recruiting
Phase 2
Efficacy and Safety of Crocin Supplementation in Patients With Central SerousChorioretinopathy (CSCR)
Overview
- Phase
- Phase 2
- Intervention
- Not specified
- Conditions
- Central serous chorioretinopathy.
- Sponsor
- Shiraz University of Medical Sciences
- Enrollment
- 40
- Status
- Recruiting
- Last Updated
- 4 years ago
Overview
Brief Summary
No summary available.
Investigators
Eligibility Criteria
Inclusion Criteria
- •age of 18\-60 years old
- •The diagnosis of CSCR based on clinical and imagining evaluation
- •informed consent
Exclusion Criteria
- •Chronic Central SerousChorioretinopathy (CSCR)
- •Laser treatment (6 months prior to enrollment)
- •Intravitreal injection (3 months prior to enrollment)
- •Other retinal diseases
- •History of eye diseases
- •Diabetes Mellitus
- •Renal or hepatic diseases
- •Allergy to saffron or crocin
- •Pregnancy or lactation
- •Beta\-blocker, diuretic, or corticosteroid (1 week prior to enrollment)
Outcomes
Primary Outcomes
Not specified
Similar Trials
Completed
Phase 3
Effect of Crocin and Metformin in patients with type 2 diabetesIRCT20170611034458N2Esfahan University of Medical Sciences60
Recruiting
Phase 3
Therapeutic effect of crocin along with chemotherapy regimens in breast cancerBreast cancer.Malignant neoplasm of breast of unspecified siteC50.9IRCT20131017015044N3Mashhad University of Medical Sciences100
Recruiting
Phase 2
Evaluation of the effect of crocin in the treatment of cystoid macular edema secondary to retinitis pigmentosaIRCT20201219049753N2Mashhad University of Medical Sciences20
Unknown
Phase 1
Crocin Supplementation in CSCRChorioretinopathy, Central SerousNCT04936490Shiraz University of Medical Sciences40
Completed
Phase 3
Effects of Crocin in Treatment of DiabetesPatients with type 2 diabetes.Diabetes mellitus due to underlying conditionIRCT20170408033308N2Shahid Beheshti University of Medical Sciences50